Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Clin Exp Pathol ; 3(7): 705-9, 2010 Aug 05.
Article in English | MEDLINE | ID: mdl-20830241

ABSTRACT

Epigallocatechin-3-gallate (EGCG) is the main polyphenol component of green tea. This compound exhibits antioxidant, immunomodulatory, photoprotective, anti-angiogenic, and anti-inflammatory properties. We conducted a small randomized, double blind, split face trial using a cream containing 2.5% w/w of EGCG. Four healthy volunteers with significant erythema and telangiectasia on the face applied EGCG cream to one side of the face, and vehicle control cream to the other, twice daily for six weeks. After six weeks, biopsies were taken from EGCG and vehicle treated sites. Immunohistochemistry was used to measure VEGF and HIF-1 α. HIF-1 α expression was decreased in EGCG treated sites, such that 28.4% of the epidermis showed positive staining in vehicle treated vs. 13.8% in EGCG treated sites (p<0.001). A similar decrease in VEGF expression was found (6.7% in EGCG vs. 11.0%in in vehicle-treated skin (p<0.005). EGCG topical treatments influence HIF-1 α induction and VEGF expression and may serve as a potential agent in the prevention of telangiectasias.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Catechin/analogs & derivatives , Erythema/drug therapy , Face/pathology , Neovascularization, Pathologic/drug therapy , Telangiectasis/drug therapy , Administration, Cutaneous , Adult , Catechin/administration & dosage , Dosage Forms , Double-Blind Method , Erythema/pathology , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis , Hypoxia-Inducible Factor 1, alpha Subunit/drug effects , Immunohistochemistry , Male , Middle Aged , Skin , Telangiectasis/pathology , Vascular Endothelial Growth Factor A/biosynthesis , Vascular Endothelial Growth Factor A/drug effects
2.
Dermatol Surg ; 36(2): 198-202, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20039920

ABSTRACT

BACKGROUND: With wrong-site surgery being one of the major causes of medical lawsuits in the United States, tools to confirm location are essential. A previous survey of 300 Mohs surgeons revealed that 14% of malpractice cases were due to wrong-site surgery. In dermatologic surgery, photography is helpful in precisely locating biopsy sites. OBJECTIVES: We present a case series of 34 biopsy-proven cutaneous head and neck malignancies performed in our university-based dermatology clinic, comparing the reliability of patient and blinded dermatologist identification with that of biopsy-site photography. RESULTS: Of 34 biopsy sites, the patient and the blinded dermatologist incorrectly identified four (12%). The patient alone incorrectly identified an additional six biopsy sites, resulting in a total of 10 (29%) cases incorrectly identified by the patient. There were no instances in which the patient correctly identified the biopsy site and the blinded dermatologist incorrectly identified it. CONCLUSION: In our current medical environment, in which more than 90% of health care is delivered in a clinic setting, wrong-site surgery is certainly underreported. In adopting a zero-tolerance policy for wrong-site surgeries, biopsy-site photography saves time, money, and potential frustration, hopefully eliminating the number of excisions performed on the wrong site.


Subject(s)
Medical Errors/prevention & control , Photography , Preoperative Care , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Aged , Aged, 80 and over , Biopsy , Diagnostic Errors , Female , Humans , Male , Middle Aged , Pilot Projects , Reproducibility of Results
3.
Exp Dermatol ; 18(6): 522-6, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19492999

ABSTRACT

BACKGROUND: Tea polyphenols have been found to exert beneficial effects on the skin via their antioxidant properties. AIMS: We sought to determine whether topical application of green tea or white tea extracts would prevent simulated solar radiation-induced oxidative damages to DNA and Langerhans cells that may lead to immune suppression and carcinogenesis. METHODS: Skin samples were analysed from volunteers or skin explants treated with white tea or green tea after UV irradiation. In another group of patients, the in vivo immune protective effects of green and white tea were evaluated using contact hypersensitivity to dinitrochlorobenzene. RESULTS: Topical application of green and white tea offered protection against detrimental effects of UV on cutaneous immunity. Such protection is not because of direct UV absorption or sunscreen effects as both products showed a sun protection factor of 1. There was no significant difference in the levels of protection afforded by the two agents. Hence, both green tea and white tea are potential photoprotective agents that may be used in conjunction with established methods of sun protection.


Subject(s)
Plant Extracts/pharmacology , Skin/drug effects , Sunscreening Agents/pharmacology , Tea/chemistry , Ultraviolet Rays/adverse effects , 8-Hydroxy-2'-Deoxyguanosine , Administration, Cutaneous , Adolescent , Adult , Antigens, CD1/analysis , DNA Adducts/analysis , DNA Damage/drug effects , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/analysis , Dermatitis, Contact/etiology , Dinitrochlorobenzene , Drug Evaluation, Preclinical , Flavonoids/pharmacology , Humans , Langerhans Cells/drug effects , Middle Aged , Phenols/pharmacology , Polyphenols , Skin/chemistry , Skin/radiation effects , Tea/classification , Young Adult
4.
Dermatitis ; 19(2): 95-9, 2008.
Article in English | MEDLINE | ID: mdl-18413111

ABSTRACT

BACKGROUND: Squaric acid dibutyl ester (SADBE) is a known contact sensitizer, but dose-response data are not defined. OBJECTIVE: To determine the relationship between sensitization dose and contact hypersensitivity (CHS) response to SADBE in human volunteers. The study also aimed to investigate whether SADBE-reactive blood T cells could be detected using ex vivo mature dendritic cells (DCs) as antigen-presenting cells. METHOD: Forty healthy volunteers were sensitized to either 12.5, 25, 50, or 250 microg of SADBE in a 48 microL volume. This was followed by elicitation 2 weeks later with five doses (0, 0.2, 2, 20, and 200 microg in 20 microL). An additional 10 subjects received the elicitation doses without prior sensitization. Blood samples obtained after sensitization were purified into T cells and mature DCs. RESULTS: A direct relationship between sensitization dose and in vivo CHS response was observed. The SADBE dose that effectively sensitized 50% of the population (ED50) was 22 microg/cm2. Significant SADBE-specific T-cell proliferation in vitro was not observed 2 weeks after sensitization but became evident after elicitation. CONCLUSION: This study establishes the in vivo dose-response characteristics of immune reactivity to SADBE and antigen-specific T-cell reactivity.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Cyclobutanes/immunology , Dermatitis, Allergic Contact/immunology , Skin/immunology , Adjuvants, Immunologic/adverse effects , Adolescent , Adult , Cell Proliferation , Coculture Techniques , Cyclobutanes/administration & dosage , Cyclobutanes/adverse effects , Dendritic Cells/immunology , Dermatitis, Allergic Contact/etiology , Dose-Response Relationship, Immunologic , Female , Humans , Immunization , Male , Middle Aged , T-Lymphocytes/immunology
5.
Photochem Photobiol ; 84(1): 180-4, 2008.
Article in English | MEDLINE | ID: mdl-18173718

ABSTRACT

Solar UV radiation is known to cause immune suppression, believed to be a critical factor in cutaneous carcinogenesis. Although the mechanism is not entirely understood, DNA damage is clearly involved. Sunscreens function by attenuating the UV radiation that reaches the epidermis. However, once DNA damage ensues, repair mechanisms become essential for prevention of malignant transformation. DNA repair enzymes have shown efficacy in reducing cutaneous neoplasms among xeroderma pigmentosum patients. In vitro studies suggest that RNA fragments increase the resistance of human keratinocytes to UVB damage and enhance DNA repair but in vivo data are lacking. This study aimed to determine the effect of topical formulations containing either DNA repair enzymes (Micrococcus luteus) or RNA fragments (UVC-irradiated rabbit globin mRNA) on UV-induced local contact hypersensitivity (CHS) suppression in humans as measured in vivo using the contact allergen dinitrochlorobenzene. Immunohistochemistry was also employed in skin biopsies to evaluate the level of thymine dimers after UV. Eighty volunteers completed the CHS portion. A single 0.75 minimum erythema dose (MED) simulated solar radiation exposure resulted in 64% CHS suppression in unprotected subjects compared with unirradiated sensitized controls. In contrast, UV-induced CHS suppression was reduced to 19% with DNA repair enzymes, and 7% with RNA fragments. Sun protection factor (SPF) testing revealed an SPF of 1 for both formulations, indicating that the observed immune protection cannot be attributed to sunscreen effects. Biopsies from an additional nine volunteers showed an 18% decrease in thymine dimers by both DNA repair enzymes and RNA fragments, relative to unprotected UV-irradiated skin. These results suggest that RNA fragments may be useful as a photoprotective agent with in vivo effects comparable to DNA repair enzymes.


Subject(s)
DNA Repair Enzymes/metabolism , DNA Repair/radiation effects , DNA/metabolism , RNA/metabolism , Adolescent , Adult , Dermatitis, Contact/genetics , Dermatitis, Contact/pathology , Dimerization , Humans , Middle Aged , Thymine/metabolism
6.
J Cutan Med Surg ; 11(2): 84-8, 2007.
Article in English | MEDLINE | ID: mdl-17374319

ABSTRACT

BACKGROUND: A 64-year-old woman presented with erythematous plaques, tender nodules, and pustules of the dorsal right hand and both legs following long-term treatment with systemic steroids and infliximab. Skin biopsy demonstrated dermal inflammation with foci of necrosis and multinucleated giant cells containing fungal spores. Tissue culture grew Trichophyton rubrum. OBJECTIVE: To report a case that demonstrates the pathophysiology of invasive T. rubrum infection, the mechanisms of action and uses of tumor necrosis factor alpha (TNF-alpha)-inhibiting drugs, and how these drugs may increase patients' risk of invasive dermatophytosis. CONCLUSION: Dermatophytes such as T. rubrum rarely cause invasive disease. This unusual presentation of invasive T. rubrum occurred with immunosuppression by infliximab and systemic steroids. Patients should have a thorough examination for signs of latent infection before TNF-alpha inhibitors are prescribed, including inspection of the skin and nails for signs of dermatophytosis.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Glucocorticoids/therapeutic use , Prednisone/therapeutic use , Tinea/physiopathology , Tumor Necrosis Factor-alpha/adverse effects , Fatal Outcome , Female , Glucocorticoids/administration & dosage , Humans , Immunocompromised Host , Infliximab , Middle Aged , Prednisone/administration & dosage , Tinea/etiology , Tinea/immunology
7.
J Am Acad Dermatol ; 56(4): 701-4, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17175066

ABSTRACT

Churg-Strauss syndrome (CSS) is a systemic vasculitis affecting both small- and medium-sized blood vessels, almost invariably affecting the lung, and frequently associated with cutaneous involvement. Microvascular vaso-occlusion leading to digital gangrene is not a feature of CSS. We report an unusual case of a patient with CSS with antiphospholipid antibodies who developed severe digital gangrene in addition to cutaneous vasculitis. The presence of antiphospholipid antibodies is not a feature usually seen in association with CSS. While the full clinical spectrum of CSS is still being defined, the identification of additional features associated with this syndrome might help to better understand the pathogenesis of the disease and to have an impact on both management and prognosis.


Subject(s)
Antibodies, Antiphospholipid/immunology , Churg-Strauss Syndrome/immunology , Churg-Strauss Syndrome/pathology , Skin/pathology , Antibodies, Antiphospholipid/blood , Azathioprine/therapeutic use , Biopsy, Needle , Churg-Strauss Syndrome/drug therapy , Disease Progression , Drug Therapy, Combination , Fingers , Gangrene/diagnosis , Gangrene/drug therapy , Humans , Immunohistochemistry , Male , Middle Aged , Prednisone/therapeutic use , Prognosis , Risk Assessment , Severity of Illness Index , Treatment Outcome
8.
Biol Blood Marrow Transplant ; 12(6): 665-71, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16737940

ABSTRACT

Whole-body UV-B phototherapy has been used for the treatment of graft-versus-host disease (GVHD) of the skin and has systemic immunosuppressive and tolerogenic effects. We hypothesized that whole-body UV-B therapy would improve donor engraftment and decrease the incidence and severity of GVHD that is associated with decreased intensity allogeneic hematopoietic stem cell transplantation. This study tested the feasibility of using UV-B phototherapy that was initiated before grafting and continued until engraftment to determine its effect on transplantation outcome. Eight patients (median age, 55.5 years; range, 32-65 years) with hematologic malignancies were included. Allogeneic peripheral blood stem cells were obtained from matched related (n=5) or matched unrelated (n=3) donors. Conditioning regimen was fludarabine 30 mg/m2 intravenously for 5 days, cyclophosphamide 1 g/m2/d intravenously for 2 days, and equine antithymocyte globulin 30 mg/kg/d for 2 days. GVHD prophylaxis included cyclosporine, methylprednisolone, and escalating doses of narrowband UV-B (311 nm) according to skin tolerance, 3 days a week, from 10 days before to 28 days after transplantation. The conditioning regimen and the UV-B therapy were well tolerated. Two patients received all 14 prescribed UV-B treatments (cumulative doses of 2000 and 3260 mJ/cm2, respectively) and 6 patients received 8 to 13 treatments with a cumulative dose range of 528-3465 mJ/cm2. There was a rapid decrease in epidermal CD1a+ cells by day of transplantation. Myeloid engraftment was rapid. One patient had secondary engraftment failure at 3 months and another had mixed chimerism at day 100. Seven of 8 patients developed severe acute GVHD (grade III, n=5; grade IV, n=2). Six had skin involvement, 5 had gastrointestinal involvement, and 1 had liver involvement. Four patients died (2 from sepsis, 1 from acute GVHD, and 1 from chronic GVHD). Four patients are alive (130-287 days), 3 with extensive chronic GVHD. We conclude that extended peritransplant UV-B therapy at the standard minimally erythemogenic dose is detrimental to the outcome of allogeneic stem cell transplantation. It is unclear how UV-B at this immunsuppressive dose might have altered skin and systemic cytokine and immune cell compositions in the host and increased GVHD- and treatment-related mortalities. Different UV-B dose and schedules should be further explored. However, although other phototherapeutic modalities may be effective against GVHD, extended UV-B therapy should not be used during early phases of decreased conditioning allogeneic transplantation.


Subject(s)
Hematologic Neoplasms/therapy , Phototherapy/adverse effects , Stem Cell Transplantation , Ultraviolet Rays , Whole-Body Irradiation/adverse effects , Adult , Aged , Antigens, CD/analysis , Antigens, CD1/analysis , Female , Humans , Male , Middle Aged , Skin/immunology , Skin/radiation effects , Transplantation Conditioning , Transplantation, Homologous , Treatment Outcome
9.
Expert Rev Anticancer Ther ; 5(6): 1061-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16336097

ABSTRACT

Compounds derived from botanical sources, such as polyphenols from tea, have been of interest as possible therapeutic agents. Their benefits in terms of cancer chemoprevention have also been investigated primarily through in vitro and animal in vivo studies. Ultraviolet light from solar radiation has been proven to initiate and promote skin cancer, which is the most common malignancy in light-skinned populations. This review discusses the effects of tea polyphenols in preventing cutaneous carcinogenesis. Although many of the mechanisms and pathways discussed may be applicable to other carcinogens, this review focuses mainly on those related to ultraviolet light-induced processes and potential action sites for tea polyphenols. Since caffeine is a component of tea, and has also been suggested as a possible chemoprotective agent, it is included in this review. Based on data from numerous studies published in the scientific literature, tea polyphenols are promising chemopreventive agents against ultraviolet-induced skin cancers. Their antioxidant properties, inhibitory effects on signal transduction pathways, cell proliferation, angiogenesis and capacity for apoptosis induction, as well as possible immune protective effects, are among the mechanisms that contribute to skin cancer prevention.


Subject(s)
Caffeine/pharmacology , Chemoprevention , Flavonoids/pharmacology , Phenols/pharmacology , Skin Neoplasms/prevention & control , Tea/chemistry , Antioxidants , Apoptosis , Cell Proliferation , Cell Transformation, Neoplastic , Humans , Matrix Metalloproteinase Inhibitors , Matrix Metalloproteinases/metabolism , Neovascularization, Pathologic , Polyphenols , Signal Transduction , Ultraviolet Rays/adverse effects
11.
Ageing Res Rev ; 2(4): 383-405, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14522242

ABSTRACT

Alterations in a wide array of physiological functions are a normal consequence of aging. Importantly, aged individuals exhibit an enhanced susceptibility to various degenerative diseases and appear less able than their young and adult counterparts to withstand (patho)physiological stress. Elucidation of mechanisms at play in the aging process would benefit the development of effective strategies for enhancing the quality of life for the elderly. It is likely that decrements in cellular and physiological function that occur during aging are the net result of numerous interacting factors. The current review focuses on the potential contribution(s) of free radical-mediated modifications to protein structure/function and alterations in the activities of two major proteolytic systems within cells, lysosomes and the proteasome, to the age-dependent accumulation of fluorescent intracellular granules, termed lipofuscin. Specifically, aging appears to influence the interplay between the occurrences of free radical-derived modifications to protein and the ability of cells to carry out critical proteolytic functions. We present immunochemical and ultrastructural evidence demonstrating the occurrence of a fluorescent protein cross-link derived from free radical-mediated reaction(s) within lipofuscin granules of rat cerebral cortex neurons. In addition, we provide evidence that a fluorophore-modified protein present in lipofuscin granules is the alpha subunit of F1F0-ATP synthase, a mitochondrial protein. It has previously been shown that protein(s) bearing this particular fluorescent cross-link are resistant to proteolysis and can inhibit the proteasome in a non-competitive fashion (J. Biol. Chem. 269 (1994a) 21639; FEBS Lett. 405 (1997) 21). Therefore, the current findings demonstrate that free radical-mediated modifications to protein(s) that lead to the production of inhibitor(s) of cellular proteolytic systems are present on specific protein components of lipofuscin. In addition, the mitochondrial origin of one of these proteins indicates specific intracellular pathways likely to be influenced by free radical events and participate in the formation of lipofuscin. The results of these studies are related to previous in vitro and in vivo observations in the field, thus shedding light on potential consequences to cellular function. In addition, future research directions suggested by the available evidence are discussed.


Subject(s)
Aging/physiology , Endopeptidases/physiology , Free Radicals/metabolism , Lipofuscin/metabolism , Animals , Cysteine Endopeptidases/metabolism , Humans , Lysosomes/metabolism , Multienzyme Complexes/metabolism , Oxidation-Reduction , Proteasome Endopeptidase Complex , Rats
SELECTION OF CITATIONS
SEARCH DETAIL